Feb 11, 2009 - Taro Pharmaceutical Industries Ltd. reported today that it has received approval from the U.S. FDA for its Abbreviated New Drug Application for Levetiracetam Oral Solution, 100 mg/mL (“levetiracetam oral solution”).
The details can be read here.
No comments:
Post a Comment